Animal Pharmaceutical Companies
Worldwide sales of vaccines, medicines and medical devices for companion animals have exceeded about $8 billion annually with an additional $14 billion in sales of vaccines and medicines for livestock. The following companies generated sales in the billions for animal pharmaceuticals.
According to the Animal Health Institute, an industry trade group, the global market for animal medicines is about one-fortieth of that spent on human medicines. The trade group estimated that today "24 billion chickens, more than 1 billion cattle and sheep, 750 million pigs and goats, 500 million dogs and 400 million cats" worldwide benefit from innovations in animal health.
Animal health drugs require approval from the Food and Drug Administration. According to the Animal Health Institute, the development of a new animal drug can take up to 10 years and cost up to $100 million prior to approval.
A new vaccine takes three to five years to develop and averages around $80 million in costs Animal health product manufacturers support the FDA approval process through user fees authorized by the Animal Drug User Fees Act (ADUF) and the Animal Generic Drug User Fee Act.
develops vaccines, parasiticides, anti-infectives, medicinal feed additives and drugs for pain, sedation, and cancers for pets and farm animals.
Merck Animal Health
manufactures vaccines, anti-infective and anti-parasitic drugs, fertility management drugs and other specialty pharmaceutical products for companion animals and livestock.
develops and markets veterinary products including anesthetics, antiparasitics, antimicrobials, and gastrointestinal, respiratory and cardiovascular medicines. It also produces vaccines for livestock, poultry, and pets.
Elanco Animal Health
develops and markets products to treat animal health and increase protein production. Products include flea protection for dogs and cats, drugs to combat parasites in poultry, and vaccines and feed additives for livestock and poultry.
Bayer HealthCare Animal Health
manufactures antimicrobials, parasiticides, sedatives, painkillers, and nutritional supplements and feed additives for dogs, cats, and horses. Products for food animals include anti-infectives, vaccines, parasiticides and sedatives and painkillers.
Boehringer Ingelheim Animal Health
markets biologicals, vaccines, pharmaceuticals and other care products for use in pets and livestock.
Novartis Animal Health
Novartis develops and markets health product for companion animals, livestock, and the aquaculture market. Popular products include treatments for dermatitis, flea protection, pain and heart-worm prevention in pets, and antibiotics and antiparasitics in farm animals. Novartis has also developed some of the first vaccines for combating viral and parasitic infections in fish. The company was acquired by Eli Lilly in 2015 for $5.4 billion.
manufactures antibiotics, vaccines, antiparasitics, dermatological and dental products for the treatment and care of pets and food animals.